CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $82,262 (100.0% shares, 0.0% debt)

Holdings (20)

— STRONGBRIDGE BIOPHARMA PLC 48.6%

Value ($000) $39,984 Shares 5,514,994 Est. Cost $2.51 Unrealized —

— MOLECULAR TEMPLATES INC 12.3%

Value ($000) $10,158 Shares 1,013,787 Est. Cost $6.97 Unrealized —

— KALA PHARMACEUTICALS INC 12.2%

Value ($000) $10,063 Shares 544,220 Est. Cost $22.84 Unrealized —

— GARRISON CAP INC 9.9%

Value ($000) $8,110 Shares 1,000,000 Est. Cost $8.46 Unrealized —

— AGILE THERAPEUTICS INC 6.0%

Value ($000) $4,896 Shares 1,820,012 Est. Cost $6.12 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 2.2%

Value ($000) $1,773 Shares 8,945 Est. Cost $132.86 Unrealized +42.9%

JBGS JBG SMITH PPTYS 1.7%

Value ($000) $1,430 Shares 41,170 Est. Cost $34.27 Unrealized —

IWM ISHARES TR 1.2%

Value ($000) $997 Shares 6,540 Est. Cost — Unrealized —

— GTX INC DEL 1.0%

Value ($000) $799 Shares 62,869 Est. Cost $8.45 Unrealized —

SPY SPDR S&P 500 ETF TR 0.8%

Value ($000) $672 Shares 2,519 Est. Cost — Unrealized —

— CM FIN INC 0.7%

Value ($000) $574 Shares 70,402 Est. Cost $9.31 Unrealized —

— ALCENTRA CAP CORP 0.6%

Value ($000) $500 Shares 59,562 Est. Cost $8.39 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 0.5%

Value ($000) $444 Shares 17,994 Est. Cost $25.00 Unrealized -2.6%

— TRIANGLE CAP CORP 0.5%

Value ($000) $385 Shares 40,580 Est. Cost $9.49 Unrealized —

— INTEC PHARMA LTD JERUSALEM 0.5%

Value ($000) $375 Shares 72,782 Est. Cost $8.94 Unrealized —

ADNT ADIENT PLC 0.5%

Value ($000) $373 Shares 4,737 Est. Cost $50.50 Unrealized +57.5%

— FS INVT CORP 0.3%

Value ($000) $226 Shares 30,706 Est. Cost $7.36 Unrealized —

MDGL MADRIGAL PHARMACEUTICALS INC 0.3%

Value ($000) $222 Shares 2,418 Est. Cost $57.12 Unrealized 0.0%

— MARINUS PHARMACEUTICALS INC 0.2%

Value ($000) $152 Shares 18,643 Est. Cost $6.17 Unrealized —

CPRX CATALYST PHARMACEUTICALS INC 0.2%

Value ($000) $129 Shares 33,110 Est. Cost $3.30 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	STRONGBRIDGE BIOPHARMA PLC	5,514,994	$39,984	48.6%	$2.51	—	SHS USD	G85347105
—	MOLECULAR TEMPLATES INC	1,013,787	$10,158	12.3%	$6.97	—	COM	608550109
—	KALA PHARMACEUTICALS INC	544,220	$10,063	12.2%	$22.84	—	COM	483119103
—	GARRISON CAP INC	1,000,000	$8,110	9.9%	$8.46	—	COM	366554103
—	AGILE THERAPEUTICS INC	1,820,012	$4,896	6.0%	$6.12	—	COM	00847L100
BRK/B	BERKSHIRE HATHAWAY INC DEL	8,945	$1,773	2.2%	$132.86	+42.9%	CL B NEW	084670702
JBGS	JBG SMITH PPTYS	41,170	$1,430	1.7%	$34.27	—	COM	46590V100
IWM	ISHARES TR	6,540	$997	1.2%	—	—	Call	464287655
—	GTX INC DEL	62,869	$799	1.0%	$8.45	—	COM NEW	40052B207
SPY	SPDR S&P 500 ETF TR	2,519	$672	0.8%	—	—	Put	78462F103
—	CM FIN INC	70,402	$574	0.7%	$9.31	—	COM	12574Q103
—	ALCENTRA CAP CORP	59,562	$500	0.6%	$8.39	—	COM	01374T102
ACRS	ACLARIS THERAPEUTICS INC	17,994	$444	0.5%	$25.00	-2.6%	COM	00461U105
—	TRIANGLE CAP CORP	40,580	$385	0.5%	$9.49	—	COM	895848109
—	INTEC PHARMA LTD JERUSALEM	72,782	$375	0.5%	$8.94	—	SHS	M53644106
ADNT	ADIENT PLC	4,737	$373	0.5%	$50.50	+57.5%	ORD SHS	G0084W101
—	FS INVT CORP	30,706	$226	0.3%	$7.36	—	COM	302635107
MDGL	MADRIGAL PHARMACEUTICALS INC	2,418	$222	0.3%	$57.12	0.0%	COM	558868105
—	MARINUS PHARMACEUTICALS INC	18,643	$152	0.2%	$6.17	—	COM	56854Q101
CPRX	CATALYST PHARMACEUTICALS INC	33,110	$129	0.2%	$3.30	0.0%	COM	14888U101